Product Information
AMITRIPTYLINE HCL 10 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0299 per EA under NDC 70710122500. Its NADAC has been published 404 times since Nov 28, 2018.
FDA first approved this application on Oct 6, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710122500
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMITRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210086FDA Approved
10/6/2017
TE Code
AB
On Market Since
12/26/2017
Pharmacological Classes
Price Statistics
The NADAC for AMITRIPTYLINE HCL 10 MG TAB has been published 404 times since Nov 28, 2018, and over the history we have for it it has declined 63.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0299 per EA |
|---|---|
| All-time high | $0.0878 (Dec 11, 2019) |
| All-time low | $0.0285 (Nov 20, 2024) |
| 52-week high | $0.0375 |
| 52-week low | $0.0294 |
| Median price | $0.0440 |
| Average price | $0.0513 |
| Largest weekly change | +30.2% (Jun 19, 2024) |
| Weeks tracked | 404 |
| Tracking since | Nov 28, 2018 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMITRIPTYLINE HCL 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMITRIPTYLINE HCL 10 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0299 per EA (NDC 70710122500), effective Aug 19, 2026.
How has the price of AMITRIPTYLINE HCL 10 MG TAB changed over time?
Over the history we have for it, the NADAC for AMITRIPTYLINE HCL 10 MG TAB has declined 63.8%. It has been tracked across 404 weekly CMS publications since Nov 28, 2018.
What are the highest and lowest recorded NADAC prices for AMITRIPTYLINE HCL 10 MG TAB?
Since Nov 28, 2018, the NADAC for AMITRIPTYLINE HCL 10 MG TAB has ranged from a low of $0.0285 (Nov 20, 2024) to a high of $0.0878 (Dec 11, 2019), with a median of $0.0440 per EA.
Are there cheaper alternatives to AMITRIPTYLINE HCL 10 MG TAB?
10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMITRIPTYLINE HCL 10 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures AMITRIPTYLINE HCL 10 MG TAB?
AMITRIPTYLINE HCL 10 MG TAB (NDC 70710122500) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.